UMMS Affiliation

Department of Psychiatry; Psychotic Disorders Program, UMass Memorial Medical Center

Publication Date

2020-11-19

Document Type

Article

Disciplines

Cellular and Molecular Physiology | Cognitive Neuroscience | Endocrinology | Mental Disorders | Psychiatry

Abstract

Objective: The present study aimed to examine whether insulin resistance and oxidative stress are associated with cognitive impairment in first-episode drug-free schizophrenia (SZ) patients.

Methods: Ninety first-episode SZ patients and 70 healthy controls were enrolled. Fasting insulin (FINS) and markers of oxidative stress [oxidized glutathione (GSSG), superoxide dismutase (SOD), nitric oxide (NO) and uric acid (UA) levels] were measured in serum before pharmacological treatment was initiated. Psychiatric symptoms and cognitive function were assessed with the Positive and Negative Syndrome Scale (PANSS) and MATRICS Consensus Cognitive Battery (MCCB), respectively. In addition, the homeostatic model assessment of insulin resistance (HOMA-IR) was also studied.

Results: HOMA-IR and serum levels of GSSG and NO were significantly higher in SZ patients than in healthy controls (P < 0.001), while the serum levels of SOD were significantly lower than in healthy controls (P < 0.001). HOMA-IR, GSSG and NO levels were significantly correlated to the total cognitive function scores of the patient group (r = -0.345,-0.369,-0.444, respectively, P < 0.05). But these factors were not co-related to the cognitive functions in the healthy control group. And, levels of SOD, UA were not associated with the total cognitive function scores in both the patient and the healthy control groups. NO was positively correlated with general pathological and the total score in the PANSS, and was negatively correlated with six cognitive domains (r = -0.316 to -0.553, P < 0.05).

Conclusions: The levels of insulin resistance and oxidative stress are elevated, and correlated with the severity of cognitive impairment in drug-naive, first-episode SZ patients. Treatment approaches targeting on reducing insulin resistance and oxidative stress may improve cognitive function in SZ patients.

Keywords

cognitive impairment, insulin resistance, oxidative stress, psychopathology, schizophrenia

Rights and Permissions

Copyright © 2020 Tao, Miao, Li, Yuan, Huang, Wang, Andreassen, Fan, Yang and Song. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

DOI of Published Version

10.3389/fpsyt.2020.537280

Source

Tao Q, Miao Y, Li H, Yuan X, Huang X, Wang Y, Andreassen OA, Fan X, Yang Y, Song X. Insulin Resistance and Oxidative Stress: In Relation to Cognitive Function and Psychopathology in Drug-Naïve, First-Episode Drug-Free Schizophrenia. Front Psychiatry. 2020 Nov 19;11:537280. doi: 10.3389/fpsyt.2020.537280. PMID: 33329081; PMCID: PMC7732418. Link to article on publisher's site

Journal/Book/Conference Title

Frontiers in psychiatry

Related Resources

Link to Article in PubMed

PubMed ID

33329081

Creative Commons License

Creative Commons Attribution 4.0 License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS